References
Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–9.
Wilson SH, Fasseas P, Orford JL, et al. Clinical outcomes of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol. 2003;42:234–40.
Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000;35:1288–94.
Eagle K, Berger P, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002;105:1257–6.
Poldermans D, Boersma E, Bax J, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med. 1999;341:1789–94.
Mangano DT, Layug EL, Wallace A, Tateo I., for the Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular mortality after noncardiac surgery. N Engl J Med. 1996;335:1713–20.
Juul A, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ. 2006;332:1482.
Yang H, Raymer K, Butler R, et al. Metoprolol after Vascular Surgery (MaVS) [abstract]. Can J Anaesth. 2004;51:A7.
Fleisher L, Beckman J, Brown K, et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology. Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. Circulation. 2006;113:2662–74.
Schwartz G, Olsson A, Ezekowitz M, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711–8.
Cannon C, Braunwald E, McCabe C, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495–504.
Thomas E, Goldman L, Mangione CM, et al. Body mass index as a correlate of postoperative complications and resource utilization. Am J Med. 1997;102:277–83.
Bouillot J-L, Fingerhut A, Paquet J-C, Hay J-M, Coggia M. Are routine preoperative chest radiographs useful in general surgery? A prospective, multicentre study in 3959 patients. Eur J Surg. 1996;162:597–604.
Smetana GW, Macpherson DS. The case against routine preoperative laboratory testing. Med Clin N Am. 2003;87:7–40.
Warner MA, Offord KP, Warner ME, Lennon RL, Conover MA, Jansson-Schumacher U. Role of preoperative smoking cessation and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc. 1989;64:609–16.
Bluman LG, Mosca L, Newman N, Simon DG. Preoperative smoking habits and postoperative pulmonary complications. Chest. 1998;113:883–9.
Nakagawa M, Tanaka H, Tsukuma H, Kishi Y. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest. 2001;120:705–10.
Cheatham M, Chapman W, Key S, Sawyers J. A meta-analysis of selective versus routine nasogastric decompression after elective laparotomy. Ann Surg. 1995;221:469–76.
Geerts W, Pineo G, Heit J, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):338S-400S.
Mismetti P, Laporte S, Darmon J, Buchmuller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001;88:913–30.
Turpie A, Bauer K, Eriksson B, Lassen M. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002;162:1833–40.
Bergqvist D, Agnelli G, Cohen A, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975–80.
Cole M, Primeau F, McCusker J. Effectiveness of interventions to prevent delirium in hospitalized patients: a systematic review. Can Med Assoc J. 1996;155:1263–8.
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper derives from the presentation: Update in Perioperative Medicine at the 29th annual session of SGIM, April 2006.
Dr. Smetana has received honoraria from Harvard Medical International/Novartis Pharma Schweiz (course director), and is on the advisory board of Safe Med Imaging Harvard Expert Panel. Dr. Cohn is on the speakers bureaus of Sanofi-Aventis and Pfizer, and has stock ownership in Astra-Zeneca, Glako, Merck, and Pfizer. Dr. Mercado has given expert testimony for ProMutual Group, Boston, MA, in the past 3 years. Dr. Jaffer has been a consultant for Astra-Zeneca and Sanofi-Aventis in the past 3 years, has received honoraria and is on the speakers bureau of Astra-Zeneca, and has received grant and research support from Astra-Zeneca in the past 3 years.
Rights and permissions
About this article
Cite this article
Smetana, G.W., Cohn, S.L., Mercado, D.L. et al. Update in perioperative medicine. J GEN INTERN MED 21, 1329–1337 (2006). https://doi.org/10.1111/j.1525-1497.2006.00630.x
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2006.00630.x